Literature DB >> 6133317

Evidence for direct production of somatostatin-14 from a larger precursor than somatostatin-28 in a phaeochromocytoma.

P Wu, E Penman, D H Coy, L H Rees.   

Abstract

Gel-filtration chromatography of an acid-extract of a phaeochromocytoma, under dissociating conditions, revealed 4 peaks of immunoreactive somatostatin (IRS) of approx. 8-10 kilodaltons (K), 6K, 3.5K and 1.6K as detected by an antiserum (R9) directed against the central region of tetradecapeptide somatostatin (S14). The 3.5K and 1.6K forms of IRS co-eluted with synthetic cyclic S28 and S14 respectively on reversed phase HPLC. Using another radioimmunoassay for the 1-14 sequence of S28 (N-peptide) a peak of immunoreactive N-peptide (IRN) with a molecular weight of approx. 4500 was observed. The antiserum (N3) used in the N-peptide assay was raised against N-Tyr N-peptide and cross-reacts less than 5% with synthetic S28. Two peaks were further characterised by partial tryptic digestion and gel-filtration chromatography. The 3.5K IRS peak was partially converted to a 1.6K IRS form together with an approximately equimolar amount of IRN with apparent molecular weight of 2500. This 2.5K IRN co-eluted both with N-Tyr N-peptide and with the IRN generated by tryptic digestion of synthetic cyclic S28. No IRN peak of this size was observed in the original extract. Tryptic digestion of the 6K IRS peak generated 3.5K and 1.6K IRS and 2.5K IRN. These results suggested that (1) this human phaeochromocytoma contains IRS very similar to the known structure of ovine and porcine S28 and S14. (2) The 6K IRS is composed of an unknown peptide sequence attached via trypsin-susceptible bond to the N-terminus of S28. (3) In this tumour S14 is being generated directly from 6K IRS and not via S28.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133317     DOI: 10.1016/0167-0115(83)90253-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

Review 1.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Biosynthesis of somatostatin in canine fundic D cells.

Authors:  T Chiba; J Park; T Yamada
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.

Authors:  J M Lundberg; A Al-Saffar; A Saria; E Theodorsson-Norheim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

4.  Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects.

Authors:  A Franco-Cereceda
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

5.  Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas.

Authors:  E Baldi; M L De Feo; P Geppetti; V Carlà; M Maggi; C Pupilli; M G Spillantini; A Brocchi; M Mannelli
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

6.  Somatostatin immunoreactivity in the cat adrenal medulla. Localization and characterization.

Authors:  S R Vincent; C H McIntosh; P B Reiner; J C Brown
Journal:  Histochemistry       Date:  1987

7.  Cotranslational and posttranslational proteolytic processing of preprosomatostatin-I in intact islet tissue.

Authors:  B D Noe; P C Andrews; J E Dixon; J Spiess
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.